Hataalii Begay, age 4, first child treated with UCSF gene therapy for Artemis-SCID When Hataalii Begay was born in a remote part of the Navajo nation he was diagnosed with a rare, usually fatal condition, Artemis-SCID. New stem cell therapy Today, thanks to a therapy developed at UCSF and funded by CIRM, he's a normal healthy … Continue reading CIRM-Funded Study of Deadly Immune Disorder Gets Boost from FDA